Approvals

  1. HIV/AIDS

    The FDA has approved a new HIV treatment for patients with limited treatment options.
    HIV AIDS

    Read more »
  2. Breast cancer

    The Food and Drug Administration (FDA) have extended the approval of Verzenio (abemaciclib) to now be a first line treatment for some types of advanced or metastatic breast cancer.
    breast cancer

    Read more »
  3. Parkinson’s disease

    FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions. 
    parkinson's disease

    Read more »
  4. Lung cancer

    Imfinzi (durvalumab), already approved for some bladder cancers, is now FDA approved for some patients with lung cancer.
    Industry news

    Read more »
  5. Prostate cancer

    The FDA has approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread, but that continues to grow despite treatment with hormone therapy.
    Industry news

    Read more »
  6. MS

    The Scottish Medicines Consortium (SMC) has approved Mavenclad (cladribine) as a treatment for highly active relapsing multiple sclerosis.
    Industry news

    Read more »
  7. Autism

    The experimental drug from Roche (balovaptan) has now been given Breakthrough Therapy Designation, potentially placing the drug on a faster path to market as the first pharmacological treatment for autism spectrum disorder (ASD). Pharmatimes, 30/01/2018.
    Industry news

    Read more »
  8. Digestive tract cancer

    Following the EMA’s approval in late 2017, the FDA has now also approved Lutathera (lutetium Lu 177 dotatate) for certain digestive tract cancers.
    Industry news

    Read more »
  9. What are the latest breakthroughs in multiple sclerosis (MS)?

    The potential of neuroprotective agents for a whole new form of treatment.

    MS

    Read more »
  10. Lymphoma

    Brentuximab vedotin (Adcetris) has now been approved by the European Commission for the treatment of patients with CD30-positive cutaneous T-cell lymphoma (CTCL) who have had at least 1 prior systemic therapy.
    Industry news

    Read more »
  11. Multiple sclerosis

    Ocrevus (ocrelizumab), the first ever FDA approved medicine for primary progressive MS has now also been approved by the EMA.
    Industry news

    Read more »
  12. Spinraza, the new medicine for spinal muscular atrophy

    Is there substance to the claims that it's a groundbreaking treatment?

    Spinraza

    Read more »